Loading...

Eisai Co., Ltd.

4523.TJPX
Healthcare
Drug Manufacturers - Specialty & Generic
¥4319.00
¥68.00(1.60%)

Eisai Co., Ltd. (4523.T) Financial Performance & Income Statement Overview

Analyze Eisai Co., Ltd. (4523.T) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.

Revenue Growth
6.42%
6.42%
Operating Income Growth
-23.28%
23.28%
Net Income Growth
9.49%
9.49%
Operating Cash Flow Growth
-46.21%
46.21%
Operating Margin
5.88%
5.88%
Gross Margin
78.62%
78.62%
Net Profit Margin
5.88%
5.88%
ROE
5.41%
5.41%
ROIC
4.58%
4.58%

Eisai Co., Ltd. (4523.T) Income Statement & Financial Overview

Review Eisai Co., Ltd. 4523.T income statement with detailed quarterly and annual figures.

MetricQ4 2024Q3 2024Q2 2024Q1 2024
Revenue$188.24B$216.14B$195.99B$189.03B
Cost of Revenue$40.60B$45.94B$42.51B$39.76B
Gross Profit$147.63B$170.21B$153.48B$149.27B
Gross Profit Ratio$0.78$0.79$0.78$0.79
R&D Expenses$46.31B$43.56B$40.03B$41.74B
SG&A Expenses$106.51B$104.52B$97.42B$99.54B
Operating Expenses$152.82B$142.64B$142.86B$135.87B
Total Costs & Expenses$193.42B$188.58B$185.37B$175.62B
Interest Income$2.09B$2.76B$2.07B$3.28B
Interest Expense$1.09B$777.00M$937.00M$715.00M
Depreciation & Amortization$9.83B$10.04B$9.97B$10.06B
EBITDA$10.90B$41.34B$24.40B$26.75B
EBITDA Ratio$0.06$0.19$0.12$0.14
Operating Income-$5.18B$27.57B$10.62B$13.41B
Operating Income Ratio-$0.03$0.13$0.05$0.07
Other Income/Expenses (Net)$5.16B$1.99B$4.94B$2.56B
Income Before Tax-$21.00M$29.55B$15.57B$15.97B
Income Before Tax Ratio-$0.00$0.14$0.08$0.08
Income Tax Expense-$627.00M$5.16B$4.01B$4.46B
Net Income$949.00M$23.79B$11.11B$10.58B
Net Income Ratio$0.005$0.11$0.06$0.06
EPS$3.36$84.31$39.19$36.95
Diluted EPS$3.36$84.31$39.19$36.95
Weighted Avg Shares Outstanding$282.05M$282.19M$283.53M$286.35M
Weighted Avg Shares Outstanding (Diluted)$282.05M$282.19M$283.53M$286.35M

Over the last four quarters, Eisai Co., Ltd.'s revenue moved from $189.03B in Q1 2024 to $188.24B in Q4 2024. Operating income in Q4 2024 was -$5.18B, with a strong operating margin of -3%. Despite fluctuations in R&D and SG&A expenses, EBITDA for Eisai Co., Ltd. remained robust at $10.90B, reflecting operational efficiency. Net income dropped to $949.00M, with an EPS of $3.36. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;